Wednesday, March 18, 2015 12:29 AM
New Look Eyewear Inc.
(BCI.TO), based here, posted record revenues for both the fourth quarter and year ended Dec. 27, 2014.
Friday, March 13, 2015 12:20 AM
DUBLIN, Ireland & IRVINE, Calif.—
(NYSE: ACT) and
(NYSE: AGN) announced at a shareholder meetings held this week that all proposals related to Actavis’
of Allergan were approved by both Actavis’ and Allergan’s shareholders.
Friday, March 06, 2015 12:26 AM
Cooper Companies, Inc.
(NYSE:COO) announced financial results for the fiscal first quarter ended Jan. 31, 2015. For the period, overall revenue rose 10 percent to $445.2 million.
Friday, March 06, 2015 12:23 AM
PADUA, Italy—The board of directors of
Safilo Group S.p.A.
(SFLG.MI) has approved the company’s consolidated financial results for the fourth quarter and the year ended Dec. 31, 2014.
Friday, March 06, 2015 12:20 AM
(OTCBB: XSPY) announced financial results for the year ended Dec. 31, 2014.
Wednesday, March 04, 2015 12:25 AM
(NYSE: LUX) reported record net sales and profits for fiscal year ending Dec. 31, 2014.
Friday, February 27, 2015 9:05 AM
(T:7731) has agreed to buy
(L:OPTS), the British retinal imaging company for £259.3 million, or $400 million in cash.
Friday, February 20, 2015 12:25 AM
(Reuters: ESSI.PA) reported a 15.4 percent increase in operating profit for the year ending December 31, 2014, along with a 12 percent rise in revenue.
Wednesday, February 18, 2015 12:23 AM
Unilens Vision Inc.
(OTCQX: UVIC) reported financial results for the second quarter and first half of fiscal year 2015, which ended Dec. 31, 2014, for the contact lens supplier.
Friday, February 06, 2015 12:23 AM
(NYSE: AGN) reported total product net sales of $1,889.0 million for the quarter ended Dec. 31, 2014, an increase of 13.8 percent increase, or 17.2 percent on a constant currency basis, compared to total product net sales in the fourth quarter of 2013.
Monday, February 02, 2015 12:26 AM
(TOKYO: 7741) reported gains in revenue and profit for the third quarter ended Dec. 31, 2014.
Monday, February 02, 2015 12:23 AM
, an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens, a proprietary optical lens implant for treating presbyopia, announced the pricing of its initial public offering of 4,166,667 ordinary shares at a public offering price of $10.00 per share, before underwriting discounts. All of the ordinary shares are being offered by Presbia.
Friday, January 30, 2015 12:23 AM
(NVS:NYSE) managed to deliver a growth in sales for fiscal year 2014, despite a sales decline in the fourth quarter of the year.
Wednesday, January 28, 2015 12:26 AM
SCHIPHOL, The Netherlands—GrandVision announced on Jan. 26 an indicative price range of between €17.50 and €21.50 a share for its planned public offering (IPO), a move anticipated for some time, as VMail has